These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 11387299

  • 1. A prospective randomized controlled study comparing two doses of gestodene in cyclic combined HRT preparations on endometrial physiology.
    Okon MA, Lee S, Laird SM, Li TC.
    Hum Reprod; 2001 Jun; 16(6):1244-50. PubMed ID: 11387299
    [Abstract] [Full Text] [Related]

  • 2. A prospective randomized controlled study comparing the morphological and biochemical responses of the endometrium to two different forms of 'period-free' hormone replacement therapy.
    Okon MA, Lee S, Laird SM, Li TC.
    Hum Reprod; 1998 Aug; 13(8):2261-5. PubMed ID: 9756307
    [Abstract] [Full Text] [Related]

  • 3. Progestational effects of combinations of gestodene on the postmenopausal endometrium during hormone replacement therapy.
    Byrjalsen I, Bjarnason NH, Christiansen C.
    Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 1):539-49. PubMed ID: 10076125
    [Abstract] [Full Text] [Related]

  • 4. Is the measurement of placental protein-14 and CA-125 in plasma and uterine flushings useful in the evaluation of peri-menopausal and post-menopausal bleeding?
    Li TC, Okon MA, Dalton CF, Heatley M, Laird SM.
    Hum Reprod; 1998 Oct; 13(1O):2895-901. PubMed ID: 9804252
    [Abstract] [Full Text] [Related]

  • 5. The measurement of CA 125 and placental protein 14 in uterine flushings in women with recurrent miscarriage; relation to endometrial morphology.
    Dalton CF, Laird SM, Serle E, Saravelos H, Warren MA, Li TC, Bolton AE.
    Hum Reprod; 1995 Oct; 10(10):2680-4. PubMed ID: 8567792
    [Abstract] [Full Text] [Related]

  • 6. Placental protein 14 (PP14) does not predict endometrial status under hormone replacement therapy.
    Haenggi W, Bersinger NA, Altermatt HJ, Birkhaeuser MH.
    Gynecol Endocrinol; 1997 Feb; 11(1):51-7. PubMed ID: 9086340
    [Abstract] [Full Text] [Related]

  • 7. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.
    Boerrigter PJ, van de Weijer PH, Baak JP, Fox H, Haspels AA, Kenemans P.
    Maturitas; 1996 May; 24(1-2):63-71. PubMed ID: 8794436
    [Abstract] [Full Text] [Related]

  • 8. Endometrial protein PP14 and CA-125 in recurrent miscarriage patients; correlation with pregnancy outcome.
    Dalton CF, Laird SM, Estdale SE, Saravelos HG, Li TC.
    Hum Reprod; 1998 Nov; 13(11):3197-202. PubMed ID: 9853880
    [Abstract] [Full Text] [Related]

  • 9. Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy.
    Byrjalsen I, Thormann L, Meinecke B, Riis BJ, Christiansen C.
    Hum Reprod; 1992 Sep; 7(8):1042-7. PubMed ID: 1400926
    [Abstract] [Full Text] [Related]

  • 10. Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.
    Hänggi W, Bersinger N, Altermatt HJ, Birkhäuser MH.
    Maturitas; 1997 Jun; 27(2):133-43. PubMed ID: 9255748
    [Abstract] [Full Text] [Related]

  • 11. Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium.
    Byrjalsen I, Thormann L, Meinecke B, Riis BJ, Christiansen C.
    Obstet Gynecol; 1992 Apr; 79(4):523-8. PubMed ID: 1532445
    [Abstract] [Full Text] [Related]

  • 12. Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles.
    Westergaard LG, Wiberg N, Andersen CY, Laursen SB, Kliem A, Westergaard JG, Teisner B.
    Hum Reprod; 1998 Sep; 13(9):2612-9. PubMed ID: 9806294
    [Abstract] [Full Text] [Related]

  • 13. Secretory endometrial protein PP14 in serum from post-menopausal women receiving continuous combined oestradiol-cyproterone acetate: correlation with serum hormone concentrations and bleeding patterns.
    Byrjalsen I, Thormann L, Riis BJ, Christiansen C.
    Maturitas; 1992 Aug; 15(1):39-46. PubMed ID: 1388220
    [Abstract] [Full Text] [Related]

  • 14. Serum placental protein 14: a novel marker of selective oestrogen receptor modulator action on the postmenopausal endometrium.
    Tankó LB, Warming L, Bagger YZ, Byrjalsen I, Jensen S, Christiansen C.
    Biomarkers; 2002 Aug; 7(3):257-66. PubMed ID: 12141068
    [Abstract] [Full Text] [Related]

  • 15. The correlation of placental protein 14 concentrations in uterine flushing and endometrial morphology in the peri-implantation period.
    Li TC, Dalton C, Hunjan KS, Warren MA, Bolton AE.
    Hum Reprod; 1993 Nov; 8(11):1923-7. PubMed ID: 8288761
    [Abstract] [Full Text] [Related]

  • 16. Can endometrial protection be inferred from the bleeding pattern on combined cyclical hormone replacement therapy.
    Burch D, Bieshuevel E, Smith S, Fox H.
    Maturitas; 2000 Feb 15; 34(2):155-60. PubMed ID: 10714910
    [Abstract] [Full Text] [Related]

  • 17. Serum placental protein 14 in pre-menopausal and post-menopausal women--dependency on oestrogen/progestogen status.
    Byrjalsen I, Riis BJ, Christiansen C.
    Maturitas; 1990 Jun 15; 12(2):79-88. PubMed ID: 2255265
    [Abstract] [Full Text] [Related]

  • 18. Correlation of serum and follicular fluid concentrations of placental protein 14 and CA-125 in in vitro fertilization-embryo transfer patients.
    Chryssikopoulos A, Mantzavinos T, Kanakas N, Karagouni E, Dotsika E, Zourlas PA.
    Fertil Steril; 1996 Oct 15; 66(4):599-603. PubMed ID: 8816623
    [Abstract] [Full Text] [Related]

  • 19. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH, Boyd ME, Colgan TJ, Ferenczy A, Fugere P, Lorrain J.
    Obstet Gynecol; 1993 Nov 15; 82(5):773-9. PubMed ID: 8414325
    [Abstract] [Full Text] [Related]

  • 20. Chlormadinone acetate versus micronized progesterone in the sequential combined hormone replacement therapy of the menopause.
    Pélissier C, Maroni M, Yaneva H, Brin S, Peltier-Pujol F, Jondet M.
    Maturitas; 2001 Oct 31; 40(1):85-94. PubMed ID: 11684377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.